drugset / Trial / NCT01406223

Mechanistic Evaluations of Pre-Cessation Therapies for Smoking Cessation

NCT01406223

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to look at brain function in order to understand how different treatments work to help people quit smoking. In this study, the investigators will look at the effects of nicotine patches, Chantix alone or Chantix paired with Zyban.

Timeline

Start
2011-07
Primary completion
2013-12
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupropion Small molecule 150 mg
Comparator Nicotine Unknown 21 mg Other
Comparator Varenicline Small molecule 1 mg

Indications